Source: Annual Congress 2006 - The challenges of managing asthma in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. S. Salvi, R. Kesarwani, A. Raghupathy, B. B. Brashier, S. Valsa, S. Gaikwad, D. R. Joshi, S. V. Ghorpade (Pune, India). Medical personnel‘s ability to use pressurized metered dose inhaler (pMDI) in India. Eur Respir J 2006; 28: Suppl. 50, 3366

Member's Comments

No comment yet.

Related content which might interest you: What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations? Source: Eur Respir J 2002; 19: 928-935 Year: 2002 Resistance to resistance Source: Annual Congress 2007 - Primary care: delivering the goods: "inhaled therapies" Year: 2007 Inhaler choice in primary practice Source: Eur Respir Rev 2005; 14: 117-122 Year: 2005 Mechanisms of exacerbation of respiratory symptoms in patients with COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Inhalation characteristics of asthmatic children (child), adults asthmatics (adult) and chronic obstructive pulmonary disease patients when they inhale through a spiromax dry powder inhaler (DPI) Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009 NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 A comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a double-blind, efficacy and safety study in Chinese adults with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006 Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 74-81 Year: 2003 Inhaler treatment options in COPD Source: Eur Respir Rev 2005; 14: 102-108 Year: 2005 A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 217-224 Year: 2002 Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 Patient preference for and satisfaction with inhaler devices Source: Eur Respir Rev 2005; 14: 109-116 Year: 2005 Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Source: Eur Respir J 2002; 19: 209-216 Year: 2002 Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Source: Eur Respir J 2003; 21: 68-73 Year: 2003 Pharmacological characterisation of indacaterol (QAB149), a novel once-daily inhaled β2-agonist, on small airways in human and rat lung slices Source: Annual Congress 2006 - Novel treatments for asthma Year: 2006 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 Improving inhaler use in COPD and the role of patient preference Source: Eur Respir Rev 2005; 14: 85-88 Year: 2005